Answers are grounded in this paper and cite their sources.
The protective effect of 200 mg doxantrazole given orally on allergen-induced bronchoconstriction has been compared with 20 mg inhaled disodium cromoglycate (DSCG) in 15 patients with bronchial asthma and immediate-type hypersensitivity. Only four out of the 15 patients showed a significant inhibition of their bronchoconstriction after the oral intake of doxantrazole. Nine patients were significantly protected by 20 mg DSCG. All patients responding to doxantrazole also responded well to DSCG.
No takes yet. Share an insight, caveat, or question.
Pauwels et al. (1976) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: